Drug
Alxn1720
Alxn1720: highest development phase Phase 1, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALXN1720 SC NCT04920370 | Phase 1 | Healthy |
Latest
No recent events.
Follow Alxn1720 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.